Munich, September 12.2018
stradoo® GmbH – leading European Life Science consultancy
GHO Capital, the European specialist investor in healthcare, has recently completed the acquisition of Linimed Gruppe, a leading provider of outpatient intensive care services across Germany, from Vitruvian Partners.
Headquartered in Jena, Linimed Gruppe is one of the largest providers of outpatient intensive care in Germany, operating through 44 clinical care locations. The Company is the leading provider of outpatient intensive care in community settings, enabling efficient care to the highest quality standards. The core service offering of Linimed consists of 24/7 intensive care in specialised community centres to patients with severe health problems (including neurological and neuromuscular diseases, obstructive respiratory diseases, restrictive thoracic diseases, premature birth, as well as other conditions).
The Company has approximately 1,100 employees and operates a portfolio of modern and functional facilities positioned mostly in Eastern and Central Germany. The high quality of Linimed facilities, coupled with high standards of care, has contributed to the attainment of best-in-class quality ratings.
The outpatient intensive care market in Germany currently consists of approximately 20,000 patients. Over the past five years, community care has risen from 12% to 31% of outpatient intensive care provision. Over the next five years, the overall number of patients is expected to increase to 26,000 with community care growing at an estimated compound annual growth rate of 16%.
Stradoo supported GHO Capital as commercial and strategic advisor on the transaction. On the back of deep industry experience and a wide range network in the care industry stradoo was able to provide GHO Capital with valuable insights into the company and the transaction.
Alan MacKay, Executive Partner & Founder of GHO Capital, commented: “At GHO we look to partner with the best healthcare businesses in Europe – working with Stradoo gave GHO valuable insights for the Linimed Gruppe transaction such that we were able to confirm our preliminary assessment of Linimed Gruppe as best in class.”